Sunesis Pharmaceuticals CEO Ivor Royston's 2021 pay jumps 666% to $5.7M
Sunesis Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Sunesis Pharmaceuticals reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, four executives at Sunesis Pharmaceuticals received on average a compensation package of $2.4M, a 228% increase compared to previous year.
Average pay of disclosed executives at Sunesis Pharmaceuticals
Ivor Royston, Chief Executive Officer, received $5.7M in total, which increased by 666% compared to 2020. 60% of Royston's compensation, or $3.4M, was in option awards. Royston also received $256K in non-equity incentive plan, $556K in salary, $1.4M in stock awards, as well as $10K in other compensation.
Lisa Rojkjaer, Chief Medical Officer, received a compensation package of $1.8M, which increased by 119% compared to previous year. 52% of the compensation package, or $919K, was in option awards.
Daniel Chevallard, Chief Financial Officer, earned $1.7M in 2021, a 163% increase compared to previous year.
Par Hyare, Chief Executive Officer, received $422K in 2021.
Related executives
You may also like
Source: SEC filing on April 27, 2022.